Maria Perez-Lanzon (María Pérez-Lanzón)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Breast Cancer Risk

Inflammatory Response

Top Venues

Genes and immunity

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Correction: Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity 25 (2) (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity 25 (2) (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Correction: Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity 25 (2) (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity (2024)
Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin, Guido Kroemer
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line. Genes and immunity 25 (2) (2024)
Jonathan G Pol, Céleste Plantureux, Maria Perez-Lanzon, Guido Kroemer
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity. Oncoimmunology 11 (1) (2022)
Adriana Petrazzuolo, Maria Perez-Lanzon, Peng Liu, M Chiara Maiuri, Guido Kroemer
Crizotinib and ceritinib trigger immunogenic cell death via on-target effects. Oncoimmunology 10 (1) (2021)
Wei Xie, Sabrina Forveille, Kristina Iribarren, Allan Sauvat, Laura Senovilla, Yan Wang, Juliette Humeau, Maria Perez-Lanzon, Heng Zhou, Juan F Martínez-Leal, Guido Kroemer, Oliver Kepp
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity. Oncoimmunology 8 (11) (2019)
Maria Perez-Lanzon, Laurence Zitvogel, Guido Kroemer
Failure of immunosurveillance accelerates aging. Oncoimmunology 8 (4) (2019)